(Q37684349)
Statements
HER2 targeting as a two-sided strategy for breast cancer diagnosis and treatment: Outlook and recent implications in nanomedical approaches (English)
Paolo Verderio
Davide Prosperi
Elisa Mazzantini
Emanuela Occhipinti